Region-Specific Enhancement of c-fos Expression by Combined Treatment With NMDA Receptor Agonists and Antagonists With Antidepressant Potential

Rapastinel, formerly Glyx-13, is a novel positive allosteric modulator of the N-methyl-D-aspartate-receptor (NMDAR) that counteracts psychotomimetic actions of NMDAR antagonists. We set out to evaluate the effect of rapastinel alone or in combination with the global and GluN2B subunit–specific NMDAR...

Descripción completa

Detalles Bibliográficos
Autores principales: Vasilescu, Andrei-Nicolae, Pfeiffer, Natascha, Terraneo, Federica, Riva, Marco Andrea, Lang, Undine E, Inta, Dragos, Gass, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9670745/
https://www.ncbi.nlm.nih.gov/pubmed/35974297
http://dx.doi.org/10.1093/ijnp/pyac051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9670745/
https://www.ncbi.nlm.nih.gov/pubmed/35974297
http://dx.doi.org/10.1093/ijnp/pyac051

Ejemplares similares